title: BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
abstract: BRCA1 germline mutations confer susceptibility to familial breast and ovarian cancer. Mutational hot spots have never been detected in BRCA1 cDNA. Some mutations have been reported several times whereas some others appear to be population-related. In this study a group of 36 Italian families were analysed for BRCA1 germline mutations. All of them were screened by allele-specific oligonucleotide hybridization (ASO) for three recurrent mutations (185delAG, 5382insC, nt332-T>G). Twenty families, selected because of their high risk of carrying BRCA1 mutations, were subjected to analysis of the entire coding sequence of the gene. A total of eight mutations were found. ASO screening demonstrated only one known mutation in one patient, whereas cycle sequencing revealed five new mutations. Three of these new mutations were frameshifts: one occurred in exon 11 (1499insA), one in exon 16 (4873delCA) and one in the splice site of exon 3 (252delAAgt). Two were missense mutations (Cys64Arg; Asn158Tyr). The same frameshift mutation, 1499insA, was detected in three unrelated families. Haplotype analysis supported the hypothesis that two of these families may have had common ancestors, whereas in the third family the analysis was uninformative. BRCA1 germline mutations were found in one out of two families with ovarian cancer, in five out of eight families with breast-ovarian cancer, and in two out of 11 families with breast cancer. All three families with 1499insA mutations included at least one case of ovarian cancer. The majority of the ovarian cancers (4/5) associated with detectable BRCA1 germline mutations were of serous histotype.
authors.affiliation: Institute of Pathology, University of Pisa, Italy.
authors.forename: M A
authors.initials: MA
authors.lastname: Caligo
authors.forename: C
authors.initials: C
authors.lastname: Ghimenti
authors.forename: G
authors.initials: G
authors.lastname: Cipollini
authors.forename: S
authors.initials: S
authors.lastname: Ricci
authors.forename: I
authors.initials: I
authors.lastname: Brunetti
authors.forename: V
authors.initials: V
authors.lastname: Marchetti
authors.forename: R
authors.initials: R
authors.lastname: Olsen
authors.forename: S
authors.initials: S
authors.lastname: Neuhausen
authors.forename: D
authors.initials: D
authors.lastname: Shattuck-Eidens
authors.forename: P F
authors.initials: PF
authors.lastname: Conte
authors.forename: M H
authors.initials: MH
authors.lastname: Skolnick
authors.forename: G
authors.initials: G
authors.lastname: Bevilacqua
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D004198:Disease Susceptibility; D005192:Family Health; D005260:Female; D016368:Frameshift Mutation / Q000235:genetics; D019398:Genes, BRCA1 / Q000235:genetics*; D005838:Genotype; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D007558:Italy / Q000453:epidemiology / Q000208:ethnology; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D017354:Point Mutation; D011110:Polymorphism, Genetic